IBDEI0EG ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6943,2)
 ;;=^338287
 ;;^UTILITY(U,$J,358.3,6944,0)
 ;;=786.30^^47^545^12
 ;;^UTILITY(U,$J,358.3,6944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6944,1,3,0)
 ;;=3^HEMOPTYSIS NOS
 ;;^UTILITY(U,$J,358.3,6944,1,4,0)
 ;;=4^786.30
 ;;^UTILITY(U,$J,358.3,6944,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,6945,0)
 ;;=V55.0^^47^545^1
 ;;^UTILITY(U,$J,358.3,6945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6945,1,3,0)
 ;;=3^ATTEN TO TRACHEOSTOMY
 ;;^UTILITY(U,$J,358.3,6945,1,4,0)
 ;;=4^V55.0
 ;;^UTILITY(U,$J,358.3,6945,2)
 ;;=^295516
 ;;^UTILITY(U,$J,358.3,6946,0)
 ;;=V65.5^^47^546^1
 ;;^UTILITY(U,$J,358.3,6946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6946,1,3,0)
 ;;=3^FEARED COMPLAINT/NO DX
 ;;^UTILITY(U,$J,358.3,6946,1,4,0)
 ;;=4^V65.5
 ;;^UTILITY(U,$J,358.3,6946,2)
 ;;=^295564
 ;;^UTILITY(U,$J,358.3,6947,0)
 ;;=V60.0^^47^546^2
 ;;^UTILITY(U,$J,358.3,6947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6947,1,3,0)
 ;;=3^HOMELESSNESS
 ;;^UTILITY(U,$J,358.3,6947,1,4,0)
 ;;=4^V60.0
 ;;^UTILITY(U,$J,358.3,6947,2)
 ;;=^295539
 ;;^UTILITY(U,$J,358.3,6948,0)
 ;;=340.^^47^546^3
 ;;^UTILITY(U,$J,358.3,6948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6948,1,3,0)
 ;;=3^MULTIPLE SCLEROSIS
 ;;^UTILITY(U,$J,358.3,6948,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,6948,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,6949,0)
 ;;=369.4^^47^547^2
 ;;^UTILITY(U,$J,358.3,6949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6949,1,3,0)
 ;;=3^LEGAL BLINDNESS-USA DEF
 ;;^UTILITY(U,$J,358.3,6949,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,6949,2)
 ;;=^268887
 ;;^UTILITY(U,$J,358.3,6950,0)
 ;;=369.00^^47^547^4
 ;;^UTILITY(U,$J,358.3,6950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6950,1,3,0)
 ;;=3^VISUAL IMPAIRMENT
 ;;^UTILITY(U,$J,358.3,6950,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,6950,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,6951,0)
 ;;=369.10^^47^547^1
 ;;^UTILITY(U,$J,358.3,6951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6951,1,3,0)
 ;;=3^BLINDNESS/LOW VISION
 ;;^UTILITY(U,$J,358.3,6951,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,6951,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,6952,0)
 ;;=369.20^^47^547^3
 ;;^UTILITY(U,$J,358.3,6952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6952,1,3,0)
 ;;=3^LOW VISION,BOTH EYES
 ;;^UTILITY(U,$J,358.3,6952,1,4,0)
 ;;=4^369.20
 ;;^UTILITY(U,$J,358.3,6952,2)
 ;;=^71924
 ;;^UTILITY(U,$J,358.3,6953,0)
 ;;=369.3^^47^547^5
 ;;^UTILITY(U,$J,358.3,6953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6953,1,3,0)
 ;;=3^VISUAL LOSS,BOTH EYES,UNSPEC
 ;;^UTILITY(U,$J,358.3,6953,1,4,0)
 ;;=4^369.3
 ;;^UTILITY(U,$J,358.3,6953,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,6954,0)
 ;;=070.54^^47^548^2
 ;;^UTILITY(U,$J,358.3,6954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6954,1,3,0)
 ;;=3^CHR HEP C W/O COMA
 ;;^UTILITY(U,$J,358.3,6954,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,6954,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,6955,0)
 ;;=070.51^^47^548^1
 ;;^UTILITY(U,$J,358.3,6955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6955,1,3,0)
 ;;=3^ACUTE HEP C W/O COMA
 ;;^UTILITY(U,$J,358.3,6955,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,6955,2)
 ;;=^331778
 ;;^UTILITY(U,$J,358.3,6956,0)
 ;;=V02.62^^47^548^3
 ;;^UTILITY(U,$J,358.3,6956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6956,1,3,0)
 ;;=3^HEPATITIS C CARRIER
 ;;^UTILITY(U,$J,358.3,6956,1,4,0)
 ;;=4^V02.62
 ;;^UTILITY(U,$J,358.3,6956,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,6957,0)
 ;;=438.11^^47^549^1
 ;;^UTILITY(U,$J,358.3,6957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6957,1,3,0)
 ;;=3^APHASIA
 ;;^UTILITY(U,$J,358.3,6957,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,6957,2)
 ;;=^317907
